Claims for Patent: 5,618,710

Summary for Patent: 5,618,710

Title:	Crosslinked enzyme crystals
Abstract:	A protein such as an enzyme of antibody is immobilized by crosslinking crystals of the protein with a multifunctional crosslinking agent. The crosslinked protein crystals may be lyophilized for storage. A preferred protein is an enzyme such as thermolysin, elastase, asparaginase, lysozyme, lipase or urease. Crosslinked enzyme crystals preferably retain at least 91% activity after incubation for three hours in the presence of a concentration of Pronase.TM. that causes the soluble uncrosslinked form of the enzyme to lose at least 94% of its initial activity under the same conditions. A preferred enzyme:Pronase.TM. ratio is 1:40. Enzyme crystals that are crosslinked may be microcrystals having a cross-section of 10.sup.-1 mm or less. Crosslinked enzyme or antibody crystals may be used in an assay, diagnostic kit or biosensor for detecting an analyte, in an extracorporeal device for altering a component of a fluid, in producing a product such as using crosslinked thermolysin crystals to produce aspartame, in separating a substance from a mixture, and in therapy.
Inventor(s):	Navia; Manuel A. (Lexington, MA), St. Clair; Nancy L. (Charlestown, MA)
Assignee:	Vertex Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:	08/017,510
Patent Claims:	1. An enzyme crystal crosslinked with a multifunctional crosslinking agent, said crosslinked enzyme crystal having resistance to exogenous proteolysis, such that said crosslinked enzyme crystal retains at least 91% of its initial activity after incubation for three hours in the presence of a concentration of Pronase.TM. that causes the soluble uncrosslinked form of the enzyme that is crystallized to form said enzyme crystal that is crosslinked to lose at least 94% of its initial activity under the same conditions. 2. The crosslinked enzyme crystal according to claim 1, wherein said crystal is a microcrystal. 3. The crosslinked enzyme crystal according to claim 1 or 2, wherein said enzyme is a hydrolase. 4. The crosslinked enzyme crystal according to claim 3, wherein said hydrolase is selected from the group consisting of thermolysin, elastase, asparaginase, lysozyme and urease. 5. The crosslinked enzyme crystal according to claim 4, wherein said hydrolase is a thermolysin. 6. The crosslinked enzyme crystal according to claim 4, wherein said hydrolase is an asparaginase. 7. The crosslinked enzyme crystal according to claim 4, wherein said hydrolase is a lysozyme. 8. The crosslinked enzyme crystal according to claim 4, wherein said hydrolase is a urease. 9. The crosslinked enzyme crystal according to claim 4, wherein said hydrolase is an elastase. 10. The crosslinked enzyme crystal according to claim 3, wherein said hydrolase is an esterase. 11. The crosslinked enzyme crystal according to claim 3, wherein said hydrolase is a lipase. 12. The crosslinked enzyme crystal according to claim 1 or 2, wherein the enzyme:Pronase.TM. ratio is 1:40. 13. The crosslinked enzyme microcrystal according to claim 2, said microcrystal having a cross-section of 10.sup.-1 mm or less.

Details for Patent 5,618,710

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2014-04-08